Amber Bio is developing a first-of-its-kind RNA writing platform using multi-kilobase edits to reach previously undruggable patient populations RALEIGH, N.C., Aug. 24, 2023 /PRNewswire/ — Today, the RD Fund (Retinal Degeneration Fund) – the venture arm of the Foundation Fighting…